Recent landmark trials, particularly the SELECT study, have provided compelling evidence for cardiovascular benefits in non-diabetic obese patients, potentially reshaping our understanding of obesity treatment paradigms
Common Period Changes You Might See Missed or delayed periods Heavier or lighter flow Shorter or longer cycles More cramping or less cramping These changes are often temporary and improve as your body gets used to the medication and your new routine
Retatrutide is now being studied as a triple-receptor medication that may shape the future of obesity medicine, but it remains investigational and should not be obtained from unverified online sellers
Shame, anxiety, and body dysmorphia often accompany years of yo-yo dieting or silent frustration
The SURMOUNT trials show consistently greater weight loss with tirzepatide compared to semaglutide, but also steeper regain after discontinuation
If youre in perimenopause or menopause and want guidance from clinicians who specialize in womens midlife health, book a virtual visit with Midi today
